Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Prescription of a once-a-day dose of atenolol.
- Morisky Score of less than or equal to 2 (explanation in 'Equitable Selection of Subjects').
- Fluency in English.
- Age 45-65 inclusive.
- Primary Care Physician consent to the patient taking part.
Exclusion Criteria:
- Patients prescribed more than two anti-hypertensive agents.
- Patients prescribed more than four medications in total.
- Patients on secondary prevention following cardiac event or stroke.
- Morisky Score of more than 2.
- Patients with visual impairment or color-blindness.
- Patients with congenital or acquired cognitive impairment.
- Patients with a cardiac pacemaker
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Adherence rates as measured using data held in the SIMpill database
|
|
Patient satisfaction with intervention as assessed by questionnaire at the end of the study.
|
|
Technical difficulties as assessed by interview at the end of the study and by review of the technical log.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
Discontinuation rates of medication as assessed at the end of trial debrief.
|
|
Changes to medication regime as assessed at the end of trial debrief.
|
|
Adverse events (e.g. hospitalisation) as assessed from the log of withdrawals from the trial.
|
|
Blood pressure as measured on enrollment and at end of trial debrief.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Joseph C. Kvedar, MD, Partners Healthcare System
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2005-P-002248
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.